Internal Medicine, Infectious Disease · Phoenix, AZ
NPI
1023222619
Since 2007
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
9305 W Thomas Rd, Suite 380
Phoenix, AZ, 85037
Phone (623) 327-4144
Groups this clinician bills Medicare through
Medicare paid, 2024
$119K
1,670 services
Medicare patients, 2024
319
Average age 73
Drug cost, 2024
$545K
299 prescriptions
Company payments, 2025
$224
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Legesse Mekonnen was code 99232 (hospital e&m - subsequent), 1,160 times for 273 patients. In total Legesse Mekonnen billed 1,670 services in 10 codes, and Medicare paid $119K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-12-28.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 1,160 | 273 | $60.22 | $70K |
| 99222 Hospital E&M - Initial | Facility | 241 | 218 | $95.34 | $23K |
| 99233 Hospital E&M - Subsequent | Facility | 144 | 99 | $91.65 | $13K |
| 99223 Hospital E&M - Initial | Facility | 71 | 67 | $130.83 | $9,289 |
| 99231 Hospital E&M - Subsequent | Facility | 29 | 20 | $38.28 | $1,110 |
By year: 2022 $113K for 1,630 services; 2023 $132K for 1,833 services; 2024 $119K for 1,670 services.
Medicare prescription drug claims, 2024
In 2024, the drug Legesse Mekonnen prescribed most often to Medicare patients was Prezcobix (Darunavir/Cobicistat), with 33 prescriptions and refills. In total Legesse Mekonnen wrote 299 Medicare prescriptions that cost $545K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Prezcobix Darunavir/Cobicistat | 33 | 33 | Under 11 | $89K |
| Genvoya Elviteg/Cob/Emtri/Tenof Alafen | 29 | 37 | Under 11 | $159K |
| Ceftriaxone Ceftriaxone Sodium | 28 | 28 | 11 | $2,579 |
| Triumeq Abacavir/Dolutegravir/Lamivudi | 25 | 25 | Under 11 | $107K |
| Ertapenem Ertapenem Sodium | 21 | 21 | 15 | $6,847 |
| Nafcillin Sodium Generic | 19 | 19 | Under 11 | $14K |
| Vancomycin Hcl Generic | 14 | 14 | Under 11 | $1,178 |
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 13 | 13 | Under 11 | $49K |
| Cefazolin Sodium Generic | 13 | 13 | Under 11 | $596 |
| Juluca Dolutegravir/Rilpivirine | 12 | 12 | Under 11 | $46K |
| Ampicillin-Sulbactam Ampicillin Sod/Sulbactam Sod | 12 | 12 | Under 11 | $2,327 |
| Daptomycin Generic | 12 | 12 | Under 11 | $25K |
| Lamivudine Generic | 11 | 11 | Under 11 | $307 |
Brand drugs: 129 claims; generic drugs: 170 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Legesse Mekonnen $224 ($224 in general payments such as food, travel and fees) from 2 companies. The largest payer was Abiomed with $144.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.